CLASS III Drug recall · Reported 21 Nov 2012 · FDA Enforcement Report
Venlafaxine ER 150mg, 30 Tabs, Generic for: Effexor, Packaged recalled
Stat Rx USA is recalling Venlafaxine ER 150mg, 30 Tabs, Generic for: Effexor, Packaged, distributed in Georgia, Tennessee. The recall was initiated on 23 Aug 2012 and the FDA has classified it as Class III.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-051-2013
- FDA event ID
- 63659
- Recalling firm
- Stat Rx USA, Gainesville, GA
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- 23 Aug 2012
- FDA classified
- 9 Nov 2012
- Reported
- 21 Nov 2012
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Labeling Errors
- Drug class
- Antidepressants
Timeline
| 23 Aug 2012 | Recall initiated by company | |
| 9 Nov 2012 | Classified by FDA | +78 days |
| 21 Nov 2012 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Labeling: Label Mix-up: Product was incorrectly labeled,"Tabs" instead of "Capsules."
Product as listed by the FDA
Venlafaxine ER 150mg, 30 Tabs bottle, Generic for: Effexor, Packaged and Distributed by: Stat Rx USA, LLC, Gainesville, GA 30501 NDC 42549-684-30
Where it was distributed
GA and TN.
Questions about this recall
Why was it recalled?
Labeling: Label Mix-up: Product was incorrectly labeled,"Tabs" instead of "Capsules."
Which lots are affected?
Lot # A00984 Exp. 01/14
Where was it sold?
GA and TN.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Stat Rx USA
All 4| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Methocarbamol 750 mg Tablets, 90-count bottle, Mfg by: West-Ward recalled | Stat Rx USA | Packaging Defects | PA |
| Drug | CLASS III | Tobramycin Ophthalmic Oint., 0.3%, (Generic for: Tobrex) recalled | Stat Rx USA | Packaging Defects | FL, PA, VA |
| Drug | CLASS III | Tizanidine (Generic for: Zanaflex), 4 mg recalled by Stat Rx U | Stat Rx USA | Packaging Defects | Nationwide |
Other Venlafaxine recalls
All 26| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Venlafaxine Tablets, USP, 75 mg recalled by Zydus Pharmaceuticals (USA)Venlafaxine | Zydus Pharmaceuticals | Foreign Material | Nationwide |
| Drug | CLASS III | Venlafaxine Extended-Release Tablets, 150mg recalled by Appco PharmaVenlafaxine | Appco Pharma | Other | Nationwide |
| Drug | CLASS II | Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg recalledVenlafaxine Hydrochloride | Zydus Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Venlafaxine Hydrochloride, extended-release capsules recalled | The Harvard Drug Group | Potency & Assay | Nationwide |
| Drug | CLASS II | Venlafaxine Tablets, USP 50 mg* recalled | SUN Pharmaceutical Industries | Other | TN |